Open | 3.7400 |
High | 3.7700 |
Low | 3.5800 |
Mkt Cap | 148.81M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.7000 |
52 Wk. Low | 2.1200 |
52 Wk. High | 6.3200 |
Related stocks
Psychedelic medicine biotech company
Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness. Wikipedia
(USD) | Q2 2023 | Y/Y |
|---|---|---|
Revenue | - | - |
Net Income | -29.13M | - |
Diluted EPS | -0.76 | - |
Quarter | EPS Estimate | EPS Actual |
|---|---|---|
Q3 2023 | -$0.67 | - |
Q2 2023 | -$0.54 | -$0.76 |
Q1 2023 | -$0.42 | -$0.65 |
S&P FuturesES=F | 4,350.75-10.25 (-0.24%) |
Dow FuturesYM=F | 34,161.00-71.00 (-0.21%) |
Nasdaq FuturesNQ=F | 14,837.75-31.75 (-0.21%) |
Paramount GlobalPARA | 12.64-4.96% |
558.59+0.63% | |
NIO Inc.NIO | 8.53+0.95% |
